Xenograft Model

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Geistlich Pharma
Geistlich PharmaSwitzerland - Root
1 program
Xenogenic collagen matrixN/A1 trial
Active Trials
NCT04980313Unknown52Est. Apr 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Geistlich PharmaXenogenic collagen matrix

Clinical Trials (1)

Total enrollment: 52 patients across 1 trials

NCT04980313Geistlich PharmaXenogenic collagen matrix

Effect of Xenogeneic Collagen Matrix on the Peri-implant Tissues of Immediate Implants.

Start: Apr 2021Est. completion: Apr 202352 patients
N/AUnknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space